ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

パルミチン酸コルホスセリル

Colfosceril Palmitate

HCID 452110
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
63-89-8
標準SMILES
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC
InChIKey
KILNVBDSWZSGLL-KXQOOQHDSA-N
分子式
C40H80NO8P
平均分子量
734 g/mol
単同位体質量
733.56215551

概要

1,2-dihexadecanoyl-sn-glycero-3-phosphocholine is a phosphatidylcholine 32:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl). A synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of pulmonary surfactants. It has a role as a surfactant and a mouse metabolite. It is a phosphatidylcholine 32:0 and a 1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine. It is functionally related to a hexadecanoic acid. It is a conjugate base of a 1,2-di-O-palmitoyl-sn-glycero-3-phosphocholine.

名称と識別子

優先名称
Colfosceril Palmitate
IUPAC
[(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
現地名
パルミチン酸コルホスセリル
英語名
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
分子式
C40H80NO8P
分子量
734.04

名称と別名

63-89-8Colfosceril palmitate1,2-Dipalmitoyl-sn-glycero-3-phosphocholinediPalmitoylphosphatidylcholinePalmitate de colfoscerilPalmitato de colfosceriloColfoscerili palmitas1,2-dihexadecanoyl-sn-glycero-3-phosphocholineColfoscerilDppc, l-Dppc, r-Dipalmitoyl lecithin, l-
名称をさらに表示
コルホスセリルパルミタート[2-[(R)-2,3-ビス[(1-オキソヘキサデシル)オキシ]プロピルオキシホスフィナトオキシ]エチル]ジメチルメタンアミニウムパルミチン酸コルホスセリル1,2-ジパルミトイル-sn-グリセロ-3-ホスホコリン1,2-ジヘキサデカノイル-sn-グリセロ-3-ホスホコリンりん酸2,3-ビス(パルミトイルオキシ)プロピル[2-(トリメチルアンモニオ)エチル]ジパルミトイルグリセロホスホコリン1,2‐ジパルミトイル‐SN‐グリセロ‐3‐ホスホリルコリンL-Α-ホスファチジルコリン, ジパルミトイルL-Α-ジパルミトイルレシチン(2R)-1-[(3-アザニウミル-3-メチルブチル ホスホナト)オキシ]-3-(ヘキサデカノイルオキシ)プロパン-2-イル ヘキサデカノアート(2-{[(2R)-2,3-ビス(ヘキサデカノイルオキシ)プロピル ホスホナト]オキシ}エチル)トリメチルアザニウムジパルミトイル-L-レシチン[2-(トリメチルアミニオ)エトキシ][(R)-2,3-ビス(ヘキサデカノイルオキシ)プロポキシ]ホスフィン酸アニオン[O-[1-O,2-O-ジ(パルミトイル)-L-グリセロ-3-ホスホ]コリン]アニオン[O-[1-O,2-O-ジ(ヘキサデカノイル)-L-グリセロ-3-ホスホ]コリン]アニオン[O-[1-O,2-O-ビス(パルミトイル)-L-グリセロ-3-ホスホ]コリン]アニオン

物性

構造計算による物性

XLogP
13.5
極性表面積
111 Ų
水素結合供与体数
0
水素結合受容体数
8
回転可能結合数
40
重原子数
50
形式電荷
0
複雑度
826

実験および物理化学的性質

Lipids · 2 件

Lipids -> Unambiguous Lipids

Lipids -> Glycerophospholipids [GP] -> Glycerophosphocholines [GP01] -> Diacylglycerophosphocholines [GP0101]

SolubilityVery poor solubility
Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Boiling Point60.5-61.5ºC at 760 mmHg
Melting Point-63ºC
Physical DescriptionSolid
Collision Cross Section · 2 件

283.9 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Sample Type: Human plasma; Dataset: Unambiguous Lipids]

281.91 Ų [M+H]+ [CCS Type: TIMS; Method: single field calibrated]

物理化学的性質

融点
229 · 229-229.5 °C
比旋光度
23 · D23 +6.6° (c = 4.2 in 1:1 chloroform-methanol)
貯蔵温度
-20 °C · -20°C

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS ClassificationNot Classified

危険有害性情報

Regulatory InformationColfosceril palmitate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesNot Classified

安全データ

F
10-21
wgk
3
hs_code
29232000
safety_code
24/25
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

ATC Code · 2 件

R - Respiratory system

QR - Respiratory system

Protein BindingColfosceril palmitate stays and gets metabolized in the pulmunar tissue, thus it is not able to bind to plasma proteins.
Pharmacodynamics · 1 件

Colfosceril palmitate has shown to significantly reduce the risk of pneumothoraces, pulmonary interstitial emphysema and mortality. Unlike naturals surfactants, colfosceril palmitate reduces the risk of bronchopulmonary dysplasia, intraventricular hemorrhage and patent ductus arteriosus. In clinical placebo-controlled trials, there was a significant reduction in the number of deaths attributed to hyaline membrane disease, the incidence of pulmonary air leaks, oxygen requirements and mean airway pressure. Some reports have indicated a lack of therapeutic effect due to the absence of surfactant protein.

Mechanism of Action · 1 件

Treatment with colfosceril palmitate aims to reinflate a collapsed area of the lung, improve compliance and reduce intrapulmonary shunting. The actions of colfosceril palmitate are perfomed by replacing the defficient or innefective endogenous lung surfactant and thus, reducing the tension and stabilizing the alveoli from collapsing. Colfosceril palmitate will form a very thin film that will cover the surface of the alveolar cells and therefore it will reduce surface tension.

Biological Half-LifeThe half-life of colfosceril palmitate is registered to be in the range of 20-36 hours.
Metabolism/MetabolitesColfosceril palmitate is catabolized and reutilized for further synthesis and secretion in lung tissues.
Absorption, Distribution and Excretion · 4 件

The absorption is done directly in the alveolus into the lung tissue. As the lung surfactant is distributed in the bronchi, bronchioles and alveoli, its highest concentration is at the alveolar air-fluid interface where it remains as a monolayer.

関連反応

13 件
反応記録を作成
HRID 37756 の反応式
HRID 37756反応物として
HRID 230978 の反応式
HRID 230978反応物として
HRID 230979 の反応式
HRID 230979反応物として
HRID 230980 の反応式
HRID 230980反応物として
HRID 399366 の反応式
HRID 399366反応物として
HRID 481280 の反応式
HRID 481280反応物として
HRID 1825693 の反応式
HRID 1825693反応物として
HRID 1865764 の反応式
HRID 1865764反応物として
前へ1 / 2 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
[(2S)-2,3-ビス(ヘキサデカノイルオキシ)プロポキシ][2-(トリメチルアザニウミル)エトキシ]ホスフィン酸
1-O,2-O-ジ(ヘキサデカノイル)-D-グリセロ-3-ホスホコリン
[(S)-2,3-ビス(パルミトイルオキシ)プロピル][2-(トリメチルアミニオ)エチル]ホスファート
DPPC
1,2-dipalmitoyl-sn-glycero-3-PC
16:0 PC
DIPALMITOYL LECITHIN
L-A-LECITHIN DIPALMITOYL
DIPALMITOYL-L-ALPHA-LECITHIN
B,G-DIPALMITOYL-L-A-LECITHIN
L-ALPHA-LECITHIN, DIPALMITOYL
DTXSID5046720129Y83319X2NFW0ADipalmitoyl glycerophosphocholine1-16:0-2-16:0-phosphatidylcholine[(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphateSURFAXIN COMPONENT DPPCDTXCID3026720

データベース識別子

CAS
63-89-8
PubChem CID
452110
DTXSID
DTXSID5046720
ChEMBL
CHEMBL1200737
ChEBI
CHEBI:72999
UNII
319X2NFW0A
EC Number
200-567-6
Nikkaji
J110.766F
溶解性
クロロホルム(微量)、メタノール(微量)
外見
個体
色
ホワイトからオフホワイト
由来生物
synthetic
Merck
14 · 14,2477
安定性
安定。強力な酸化剤とは相容れない。
化粧品成分の機能
スキンコンディショニング
InChIKey
KILNVBDSWZSGLL-KXQOOQHDSA-N
SMILES
[C@@H](OC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C |&1:0,r|
CAS データベース
63 · 63-89-8(CAS DataBase Reference)

化学的性質

化学的特性white powder

After 5 days, most of the administered dose (56%) is distributed throughout the body with renal and fecal excretion being the minor elimination pathway representing the 4 and 2% of the eliminated dose respectively. The major route of elimination is by expelled air which accounts for 28% of the administered dose.

Colfosceril palmitate is distributed uniformly to all lobes of the lung, distal airways and alveolar spaces. It will not enter the systemic circulation in healthy lungs, however when the integrity of the tissue is distrupted colfosceril can reach systemic circulation. Even 5 days after administration, there are traces of colfosceril palmitate retained in the body that represented 72% of the administered dose which by then have entered pathways of lipid metabolism to become tissue associated.

After 5 days of drug administration, the lung and liver would contain 10% of the administered dose and the elimination via renal excretion accounts only for 8% of the administered dose. This proved a very small renal clearance and confirmed that the major elimination route is by expired air.

Tissue LocationsPlacenta
Cellular LocationsCytoplasm
Metabolite PathwaysPhosphatidylcholine Biosynthesis PC(16:0/16:0)
応用分野 · 3 件

用途生体膜モデル、リポソーム調製用。

使用1,2-dipalmitoyl-sn-glycero-3-phosphocholine is a major phospholipid constituent and primary surface tension lowering component of natural lung surfactant. Colfosceril Palmitate is used as pulmonary surfactant and diagnostic aid (fetal lung maturity).

一般的な説明1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine is a strong bilayer-forming lipid. It the most common phospholipid in mammalian membranes. It is also an important component of the mucosal layer of the colon.

調製方法 · 1 件

純化方法It has three crystalline forms 1, 2 and ' which change at 60-70o and at 229o, respectively. In order to obtain a fine powder, ~2 g are dissolved in CHCl3 (15mL) and pet ether (b 35-60o) is added; the solution is evaporated to dryness in vacuo at <20o and then dried at 0.1mm over CaCl2. [Baer & Maurukas J Am Chem Soc 74 158 1952, Baer & Kates J Biol Chem 185 615 1950, Beilstein 4 IV 1463.]

上流・下流製品情報

上流原料

スペリノンHexadecanoic acid, 1,1'-[1-[[(2-oxido-1,3,2-dioxaphospholan-2-yl)oxy]methyl]-1,2-ethanediyl] ester[S,(+)]-1-O,2-O-ジパルミトイル-3-O-トリチル-L-グリセロール2-クロロエチルホスホリルジクロリドコリンアルホスセラート1-O,2-O-ジヘキサデカノイル-L-グリセロールトシル酸コリンパルミチン酸トリメチルアミン水溶液 3 0 %

下流製品

1,2-Dipalmitoyl-sn-glycero-3-phosphobutanol (sodium salt)
補足説明 · 2 件

定義本品は、次の化学式で表される有機化合物である。

定義ChEBI: A phosphatidylcholine 32:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl). A synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of pulmonary surfactants.